CSS
CINC

Cubist Systematic Strategies’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Cubist Systematic Strategies’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-36,019
Closed -$443K – 4776
2022
Q4 		$443K Buy
36,019
+29,719
+472% +$708K ﹤0.01% 3111
2022
Q3 		$207K Sell
6,300
-5,100
-45% -$144K ﹤0.01% 3742
2022
Q2 		$215K Buy
11,400
+9,600
+533% +$184K ﹤0.01% 3652
2022
Q1 		$32K Buy
+1,800
New +$36.9K ﹤0.01% 3438

Cubist Systematic Strategies's CINC Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 36,019 shares — an estimated $443K sold.

Cubist Systematic Strategies first reported a position in CINC in Q1 2022 and held it in 4 quarters. The position peaked at $443K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Cubist Systematic Strategies reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 36,019 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $443K.
  • Cubist Systematic Strategies first reported a position in CinCor Pharma, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Cubist Systematic Strategies's CinCor Pharma, Inc. Common Stock position peaked at $443K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.